Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31774 ↗At a glance
Multizentrische Studie in Pediatric Blood & Cancer, 2025. Written by Catherine B Beckhorn and 59 co-authors. Institution: Duke University School of Medicine, Durham, North Carolina, USA. Major MEDLINE topics: Kidney Neoplasms, Carcinoma, Medullary. Cited 2 times so far (Crossref); 37 references.
Topics: Kinderkrankenpflege
Abstract (original language)
Background
Renal medullary carcinoma (RMC) is an aggressive tumor associated with sickle cell trait. Despite treatment advances for other rare renal tumors, RMC survival remains poor. We aimed to describe the contemporary management and survival of children and adults with RMC. Procedure In this multicenter retrospective cohort study, Pediatric Surgical Oncology Research Collaborative sites searched their databases for patients diagnosed with RMC (2000–2022). Descriptive statistics were calculated and survival analyses performed using Kaplan–Meier and Cox regression.
Results
Thirty‐four patients with RMC were identified. Median age was 19 years (IQR: 15–28; range: 7–52). Most were male (24/34; 71%), Black (27/32; 84%), had sickle cell trait or disease (30/33; 91%), presented with metastatic disease (27/34; 79%), and were symptomatic at presentation (32/34; 94%). Median overall survival (OS) was 24 months from diagnosis (16 months for children, 28 months for adults, p = 0.6). Receipt of platinum‐based chemotherapy (23/34; 68%) was associated with significantly higher OS than other regimens (35 vs. 5 months, p < 0.001). Nephrectomy (24/34; 71%) was associated with significantly improved OS compared with non‐operative management (34 vs. 7 months, p = 0.001). Immunotherapy, targeted therapy, or radiation therapy were not associated with significant differences in OS, nor were age, sex, race, sickle cell status, SMARCB1/INI‐1, stage, nephrectomy approach, retroperitoneal lymph node dissection, gross residual disease, margins, or tumor size.
Conclusions
RMC survival remains poor despite newer therapies. Nephrectomy and platinum‐based chemotherapy should be considered in locally advanced and metastatic disease. Coordinated international cooperative group studies are needed to meaningfully improve RMC survival.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Duke University School of Medicine, Durham, North Carolina, USA.
- Division of Pediatric General and Thoracic Surgery, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Pediatric Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
- Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Division of Pediatric Surgery, Department of Surgery, University of Utah, Primary Children's Hospital, Salt Lake City, Utah, USA.
ORCID profiles: Catherine B Beckhorn, Marcus M Malek, Zachary J Kastenberg, David W Hoyt, Nicholas G Cost, Charles R Marchese, Timothy B Lautz, John Lundstedt, Joseph G Brungardt, Lindsay J Talbot, Andrew J Murphy, Jennifer H Aldrink, Nelson Piché, Sindhu V Mannava, Elizabeth Fialkowski, Barrie S Rich, Natashia M Seemann, Michael Stellon, Alexandra M Dimmer, Keyonna Williams
Cite
APA
Beckhorn, C. B., Malek, M. M., Lovvorn, H. N., Leraas, H. J., McKay, K. G., Kontchou, N. T., Kastenberg, Z. J., Hoyt, D. W., Roach, J. P., Myers, E. K., Cost, N. G., Mullapudi, B., Marchese, C. R., Jensen, A. R., Lautz, T. B., Carter, M., Dasgupta, R., Lundstedt, J., Brungardt, J. G., …, & Grant, C. N. (2025). Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31774
Vancouver
Beckhorn CB, Malek MM, Lovvorn HN, Leraas HJ, McKay KG, Kontchou NT, et al. Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31774
BibTeX
@article{Beckhorn2025,
author = {Beckhorn, Catherine B and Malek, Marcus M and Lovvorn, Harold N and Leraas, Harold J and McKay, Katlyn G and Kontchou, Nelly-Ange T and Kastenberg, Zachary J and Hoyt, David W and Roach, Jonathan P and Myers, Emily K and Cost, Nicholas G and Mullapudi, Bhargava and Marchese, Charles R and Jensen, Amanda R and Lautz, Timothy B and Carter, Michela and Dasgupta, Roshni and Lundstedt, John and Brungardt, Joseph G and Talbot, Lindsay J and Davidoff, Andrew M and Murphy, Andrew J and Aldrink, Jennifer H and Mansfield, Sara A and Piché, Nelson and Lal, Dave R and Craig, Brian T and Schuh, Jennifer M and Cromeens, Barrett P and Mannava, Sindhu V and Castle, Shannon L and Lopez, Adriana and Mello, Kelsey and Short, Joshua and Petroze, Robin T and Rajavel, Shay and Thompson, Grace R and Mattei, Peter and Rothstein, David H and Fialkowski, Elizabeth and Fowler, Kathryn L and Martchenke, Nathan and Rich, Barrie S and Glick, Richard D and Brown, Erin G and Doyle, Kathleen and Abril, Paige and Rinehardt, Hannah N and Seemann, Natashia M and Davidson, Jacob and Wilson, Claire A and Le, Hau D and Joshi, Devashish and Stellon, Michael and Ahmed, Tamer and Dimmer, Alexandra M and Newman, Erika A and Hammoud, Maya and Williams, Keyonna and Grant, Christa N},
title = {Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31774}
}
EUVIMED